股本结构
单位：万股
| 公告日期 | 2024-03-25 | 2024-03-25 | 2023-11-14 | 2023-11-14 | 2023-08-14 | 2023-06-02 |
|---|---|---|---|---|---|---|
| 证券总股本 | 8206.84 | 8189.83 | 7868.59 | 7834.24 | 7813.64 | 7617.98 |
| 普通股本 | 8206.84 | 8189.83 | 7868.59 | 7834.24 | 7813.64 | 7617.98 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-15 | 2023-12-31 | 2023-11-07 | 2023-09-30 | 2023-06-30 | 2023-06-05 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-03-25 | 8206.84 | 未披露 | 定期报告 | 2024-03-15 |
| 2024-03-25 | 8189.83 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Common stock issued for cash, net of issuance costs and allocation to warrant liability
Common stock repurchased and retired
Common stock issued for settlement of RSUs
|
2023-12-31 |
| 2023-11-14 | 7868.59 | 未披露 | 定期报告 | 2023-11-07 |
| 2023-11-14 | 7834.24 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Common stock issued for settlement of RSUs
|
2023-09-30 |
| 2023-08-14 | 7813.64 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Common stock issued for cash, net of issuance costs and allocation to warrant liability
Common stock issued for settlement of RSUs
|
2023-06-30 |
| 2023-06-02 | 7617.98 | 未披露 |
更多>>
Common Stock offered by the company 13,000,000 shares
|
2023-06-05 |
| 2023-05-10 | 6317.98 | 未披露 | 定期报告 | 2023-05-03 |
| 2023-04-28 | 6314.41 | 未披露 | 定期报告 | 2023-04-24 |
| 2023-06-02 | 6311.18 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Common stock issued for cash
Common stock issued for settlement of RSUs
Common stock repurchased
|
2023-03-31 |
| 2023-03-15 | 6309.68 | 未披露 | 定期报告 | 2023-03-08 |
| 2023-02-21 | 6243.98 | 未披露 |
更多>>
Common stock offered 4,300,000 shares by the company
|
2023-02-22 |
| 2023-02-21 | 5813.98 | 未披露 | 定期报告 | 2023-02-10 |
| 2023-03-15 | 5787.34 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Common stock issued for settlement of RSUs
Common stock issued in public offerings, net
|
2022-12-31 |
| 2022-11-14 | 5752.14 | 未披露 | 定期报告 | 2022-11-07 |
| 2022-11-14 | 5749.60 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Common stock issued for cash
Common stock issued for settlement of RSUs
|
2022-09-30 |
| 2022-08-10 | 5729.70 | 未披露 | 定期报告 | 2022-08-04 |
| 2022-08-02 | 5679.03 | 未披露 |
更多>>
1.Common stock offered by 56,790,261 shares
2.Unless otherwise indicated, the number of shares of common stock to be outstanding immediately after this offering is based on 53,790,261 shares of common stock outstanding as of March 31, 2022
|
2022-08-02 |
| 2022-05-11 | 5384.70 | 未披露 | 定期报告 | 2022-05-05 |
| 2022-05-11 | 5379.03 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Common stock issued for cash
Common stock issued for settlement of RSUs
|
2022-03-31 |
| 2022-03-30 | 5377.53 | 未披露 | 定期报告 | 2022-03-25 |
| 2022-03-30 | 5377.23 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Common stock issued for cashless exercise of stock options
Common stock issued for settlement of RSUs
Common stock issued in public offerings, net
|
2021-12-31 |
| 2021-11-10 | 5353.62 | 未披露 | 定期报告 | 2021-11-04 |
| 2021-11-10 | 5322.38 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Common stock issued for cash
|
2021-09-30 |
| 2021-09-24 | 5322.24 | 未披露 | 定期报告 | 2021-09-22 |
| 2021-08-11 | 5314.52 | 未披露 | 定期报告 | 2021-08-05 |
| 2021-08-11 | 5314.41 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Common stock issued for cash
Common stock issued for cashless exercise of stock options and settlement of RSUs
|
2021-06-30 |
| 2021-04-29 | 5289.27 | 未披露 | 定期报告 | 2021-04-19 |
| 2021-05-11 | 5287.10 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Common stock issued for cash
Common stock issued for cashless exercise of stock options and settlement of RSUs
|
2021-03-31 |
| 2021-03-22 | 5287.09 | 未披露 | 定期报告 | 2021-03-10 |
| 2021-02-12 | 5187.41 | 未披露 |
更多>>
1.Common Stock offered 3,809,524 shares by the company
2.Unless otherwise indicated, the number of shares of common stock to be outstanding immediately after this offering is based on 48,064,575 shares of common stock outstanding as of September 30, 2020.
|
2021-02-12 |
| 2021-03-22 | 4860.70 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Common stock issued for Director compensation in Volition Germany
Common stock repurchase and retirement
Common stock issued in exercise of stock options
Common stock issued for exercise of warrants
Common stock issued in public offering, net
|
2020-12-31 |
| 2020-11-12 | 4819.77 | 未披露 | 定期报告 | 2020-11-04 |
| 2020-11-12 | 4806.46 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Common stock issued in public offering, net
Common stock issued in exercise of stock options
Common stock issued for cash exercise of warrants
|
2020-09-30 |
| 2020-08-13 | 4792.04 | 未披露 | 定期报告 | 2020-08-06 |
| 2020-08-13 | 4665.96 | 未披露 |
更多>>
from March 31, 2020 to June 30, 2020
Common stock issued for cash, net
|
2020-06-30 |
| 2020-05-22 | 4622.64 | 未披露 |
更多>>
VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company that applies its NucleosomicsTM platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases, announced today the closing of its previously announced underwritten public offering of an aggregate of 5,019,750 shares of common stock, including the exercise in full of the overallotment option, at a public offering price of $2.75 per share for total gross proceeds of $13.8 million, before deducting underwriting discounts, commissions and estimated offering expenses payable by Volition.
|
2020-05-22 |
| 2020-05-07 | 4120.66 | 未披露 |
更多>>
from December 31, 2019 to March 31, 2020
Common stock issued for Director compensation in Volition Germany
Common stock issued for cashless exercise of stock options
Stock repurchase
|
2020-03-31 |
| 2020-02-07 | 4120.47 | 未披露 | 定期报告 | 2020-01-31 |
| 2020-02-20 | 4112.53 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Common stock issued for cash
Common stock issued for cashless exercise of stock options
|
2019-12-31 |
| 2019-11-12 | 4109.23 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Common stock issued for cash
Common stock issued for cashless exercise of stock options
|
2019-09-30 |
| 2019-08-12 | 4108.99 | 未披露 | 定期报告 | 2019-08-07 |
| 2019-08-12 | 3948.07 | 未披露 |
更多>>
From March 31, 2019 to May 7, 2019
Common stock issued for cash
|
2019-05-07 |
| 2019-05-08 | 3781.40 | 未披露 |
更多>>
from December 31, 2018 to March 12, 2019
Common stock issued for cash
|
2019-03-12 |
| 2019-03-13 | 3533.54 | 未披露 |
更多>>
from December 31, 2017 to November 2, 2018
Common stock issued for cash, net
Common stock issued for cashless exercise of stock options
|
2018-11-02 |
| 2018-09-10 | 3503.12 | 未披露 | 定期报告 | 2018-08-31 |
| 2018-07-20 | 3003.12 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-10 | 3003.08 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-03-01 | 2653.08 | 未披露 | 定期报告 | 2018-02-27 |
| 2018-03-01 | 2651.94 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Common stock issued for cash
Common stock issued for cashless exercise of stock options
|
2017-12-31 |
| 2017-08-10 | 2651.87 | 未披露 | 定期报告 | 2017-08-09 |
| 2017-07-24 | 2650.37 | 未披露 | 定期报告 | 2017-07-14 |
| 2017-08-10 | 2646.87 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-05-11 | 2636.03 | 未披露 | 定期报告 | 2017-05-05 |
| 2017-05-11 | 2614.55 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-10 | 2612.60 | 未披露 |
更多>>
From December 31, 2015 to December 31, 2016
Common stock issued for cash, net of issuance costs
Common stock issued for cashless exercise of stock options
|
2016-12-31 |
| 2016-11-10 | 2609.31 | 未披露 | 定期报告 | 2016-11-10 |
| 2016-11-10 | 2360.87 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-11 | 2352.12 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-05-13 | 2340.05 | 未披露 | 定期报告 | 2016-05-13 |
| 2016-05-13 | 2339.79 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-03-11 | 1876.33 | 未披露 |
更多>>
From December 31, 2014 to December 31, 2015
Common stock issued for cash
Common stock issued for cashless exercise of stock options
|
2015-12-31 |
| 2015-11-04 | 1847.22 | 未披露 | 定期报告 | 2015-11-04 |
| 2015-11-04 | 1807.22 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-09-16 | 1805.97 | 未披露 | 定期报告 | 2015-09-01 |
| 2015-08-11 | 1805.97 | 未披露 | 定期报告 | 2015-08-11 |
| 2015-08-11 | 1803.47 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-05-12 | 1793.47 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-03-18 | 1793.47 | 未披露 | 定期报告 | 2015-03-18 |
| 2015-02-09 | 1716.63 | 未披露 | 定期报告 | 2015-02-06 |
| 2015-03-18 | 1469.13 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Common stock issued for cash
Common stock issued for debt
Common stock issued under deferred contingency rights
|
2014-12-31 |
| 2014-11-28 | 1430.90 | 未披露 | 定期报告 | 2014-09-30 |
From December 31, 2022 to December 31, 2023
Common stock issued for cash, net of issuance costs and allocation to warrant liability
Common stock repurchased and retired
Common stock issued for settlement of RSUs
From June 30, 2023 to September 30, 2023
Common stock issued for settlement of RSUs
From March 31, 2023 to June 30, 2023
Common stock issued for cash, net of issuance costs and allocation to warrant liability
Common stock issued for settlement of RSUs
Common Stock offered by the company 13,000,000 shares
From December 31, 2022 to March 31, 2023
Common stock issued for cash
Common stock issued for settlement of RSUs
Common stock repurchased
Common stock offered 4,300,000 shares by the company
From December 31, 2021 to December 31, 2022
Common stock issued for settlement of RSUs
Common stock issued in public offerings, net
From June 30, 2022 to September 30, 2022
Common stock issued for cash
Common stock issued for settlement of RSUs
1.Common stock offered by 56,790,261 shares
2.Unless otherwise indicated, the number of shares of common stock to be outstanding immediately after this offering is based on 53,790,261 shares of common stock outstanding as of March 31, 2022
From December 31, 2021 to March 31, 2022
Common stock issued for cash
Common stock issued for settlement of RSUs
From December 31, 2020 to December 31, 2021
Common stock issued for cashless exercise of stock options
Common stock issued for settlement of RSUs
Common stock issued in public offerings, net
From June 30, 2021 to September 30, 2021
Common stock issued for cash
From March 31, 2021 to June 30, 2021
Common stock issued for cash
Common stock issued for cashless exercise of stock options and settlement of RSUs
From December 31, 2020 to March 31, 2021
Common stock issued for cash
Common stock issued for cashless exercise of stock options and settlement of RSUs
1.Common Stock offered 3,809,524 shares by the company
2.Unless otherwise indicated, the number of shares of common stock to be outstanding immediately after this offering is based on 48,064,575 shares of common stock outstanding as of September 30, 2020.
from December 31, 2019 to December 31, 2020
Common stock issued for Director compensation in Volition Germany
Common stock repurchase and retirement
Common stock issued in exercise of stock options
Common stock issued for exercise of warrants
Common stock issued in public offering, net
From June 30, 2020 to September 30, 2020
Common stock issued in public offering, net
Common stock issued in exercise of stock options
Common stock issued for cash exercise of warrants
from March 31, 2020 to June 30, 2020
Common stock issued for cash, net
VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company that applies its NucleosomicsTM platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases, announced today the closing of its previously announced underwritten public offering of an aggregate of 5,019,750 shares of common stock, including the exercise in full of the overallotment option, at a public offering price of $2.75 per share for total gross proceeds of $13.8 million, before deducting underwriting discounts, commissions and estimated offering expenses payable by Volition.
from December 31, 2019 to March 31, 2020
Common stock issued for Director compensation in Volition Germany
Common stock issued for cashless exercise of stock options
Stock repurchase
from December 31, 2018 to December 31, 2019
Common stock issued for cash
Common stock issued for cashless exercise of stock options
From June 30, 2019 to September 30, 2019
Common stock issued for cash
Common stock issued for cashless exercise of stock options
From March 31, 2019 to May 7, 2019
Common stock issued for cash
from December 31, 2018 to March 12, 2019
Common stock issued for cash
from December 31, 2017 to November 2, 2018
Common stock issued for cash, net
Common stock issued for cashless exercise of stock options
from December 31, 2016 to December 31, 2017
Common stock issued for cash
Common stock issued for cashless exercise of stock options
From December 31, 2015 to December 31, 2016
Common stock issued for cash, net of issuance costs
Common stock issued for cashless exercise of stock options
From December 31, 2014 to December 31, 2015
Common stock issued for cash
Common stock issued for cashless exercise of stock options
from December 31, 2013 to December 31, 2014
Common stock issued for cash
Common stock issued for debt
Common stock issued under deferred contingency rights